Withdrawals due to adverse events · hypertension in adults with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · people with inflammatory bowel disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with primary hypertension
1 finding from 1 review
Withdrawals due to adverse events · people with primary hypertension
It is very uncertain whether combination therapy changes withdrawals due to adverse effects compared with monotherapy (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Propafenone probably leads to higher withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Flecainide showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Quinidine showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Metoprolol leads to higher withdrawals due to adverse effects compared with placebo or no treatment (high certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Amiodarone may leads to higher withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Dofetilide showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Dronedarone probably leads to higher withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Sotalol probably leads to higher withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Disopyramide showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
1 finding from 1 review
Intervention not reported
Withdrawals due to adverse effects · adults with or without hypertension
1 finding from 1 review
Withdrawals due to adverse events · older adults with primary hypertension
Higher BP target (< 150‐160/95‐105 mmHg) showed no clear difference in withdrawals due to adverse effects compared with lower BP target (< 140/90 mmHg) (low certainty).
1 finding from 1 review
Intervention not reported
Withdrawals due to adverse effects · patients with primary hypertension
1 finding from 1 review
Intervention not reported
Withdrawals due to adverse effects 5 years · Adults with mild hypertension and no cardiovascular disease
The intervention probably leads to higher withdrawals due to adverse effects 5 years (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse outcomes · women aged 16 and over with uncomplicated vulvovaginal candidiasis
1 finding from 1 review
Withdrawals due to adverse events · cardiovascular disease with high blood pressure
It is very uncertain whether lower blood pressure targets changes participant withdrawals due to adverse effects compared with standard blood pressure targets (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · hyperuricaemia in people with hypertension
Uric acid‐lowering drug showed no clear difference in adverse events (withdrawals due to side effects) compared with placebo (low certainty).
1 finding from 1 review